Vyome Holdings (HIND) EBT (QoQ) (2015 - 2026)
Vyome Holdings (HIND) EBT (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - |
| 10 | Vyome Holdings | 16.04 Mn | 8.15 Mn | 11,658.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 21.10% |
| Mar 31, 2026 | 7.98% |
| Dec 31, 2025 | 83.90% |
| Sep 30, 2025 | -227.99% |
| Jun 30, 2025 | -277.04% |
| Mar 31, 2025 | 184.34% |
| Dec 31, 2024 | -11.49% |
| Sep 30, 2024 | 0.32% |
| Jun 30, 2024 | 27.49% |
| Mar 31, 2024 | -30.71% |
| Dec 31, 2023 | 52.79% |
| Sep 30, 2023 | -1.20% |
| Jun 30, 2023 | -31.76% |
| Mar 31, 2023 | 83.98% |
| Dec 31, 2022 | -31.68% |
| Sep 30, 2022 | -33.00% |
| Jun 30, 2022 | -16.70% |
| Mar 31, 2022 | 78.47% |
| Dec 31, 2021 | -118.75% |
| Sep 30, 2021 | -344.55% |